Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors.
Dasari A, Phan A, Gupta S, Rashid A, Yeung SC, Hess K, Chen H, Tarco E, Chen H, Wei C, Anh-Do K, Halperin D, Meric-Bernstam F, Yao J. Dasari A, et al. Among authors: halperin d. Endocr Relat Cancer. 2015 Jun;22(3):431-41. doi: 10.1530/ERC-15-0002. Epub 2015 Apr 21. Endocr Relat Cancer. 2015. PMID: 25900182 Free PMC article. Clinical Trial.
Clinical Trial Design in Neuroendocrine Tumors.
Halperin DM, Yao JC. Halperin DM, et al. Hematol Oncol Clin North Am. 2016 Feb;30(1):209-17. doi: 10.1016/j.hoc.2015.09.011. Hematol Oncol Clin North Am. 2016. PMID: 26614378 Review.
Update on management of midgut neuroendocrine tumors.
Mehrvarz Sarshekeh A, Halperin DM, Dasari A. Mehrvarz Sarshekeh A, et al. Int J Endocr Oncol. 2016 May;3(2):175-189. doi: 10.2217/ije-2015-0004. Epub 2016 Apr 8. Int J Endocr Oncol. 2016. PMID: 27347369 Free PMC article.
403 results